CSIMarket
 
Heart Test Laboratories Inc   (HSCS)
Other Ticker:  
 
 
Price: $0.1180 $0.00 1.375%
Day's High: $0.1199 Week Perf: -0.67 %
Day's Low: $ 0.11 30 Day Perf: -12.53 %
Volume (M): 740 52 Wk High: $ 1.49
Volume (M$): $ 87 52 Wk Avg: $0.62
Open: $0.12 52 Wk Low: $0.11



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 11
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) -6
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 0

Heart Test Laboratories Inc
Heart Test Laboratories Inc is a medical diagnostic company that focuses on heart health. They offer a range of tests and services to assess and monitor heart conditions in patients. Their innovative technology and skilled team of professionals enable accurate and efficient heart screenings, aiming to provide early detection and prevention of cardiovascular diseases. They are dedicated to improving patient outcomes and reducing the risks associated with heart-related conditions.


   Company Address: 550 Reserve Street Southlake 76092 TX
   Company Phone Number: 237-7781   Stock Exchange / Ticker: NASDAQ HSCS
   HSCS is expected to report next financial results on March 15, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Heart Test Laboratories Inc

Advanced Heart Test Laboratories Inc. Witnesses Promising Revenue Similar to Previous Year's Quarter, as Efforts Focus on Q1 2024



Heart Test Laboratories Inc, a medical device manufacturing company, recently released its financial results for the first quarter of the 2024 earnings season. The figures demonstrate a significant decrease in loss per share compared to the previous year, as well as an improvement in earnings per share. Although the revenue remained unchanged, the company reported a lower net shortfall compared to the same reporting season the previous year. This article aims to provide an overview of Heart Test Laboratories Inc's Q1 2024 financial results and analyze them within the context of recent stock performance.
Financial Results:
Heart Test Laboratories Inc reported a loss per share of $-0.13 in the first quarter of 2024, a considerable improvement from the loss per share of $-0.28 in the same reporting season the previous year. Additionally, the company's earnings per share increased from $-0.16 in the previous reporting season. Despite these positive developments, the revenue for Q1 2024 remained unchanged at $0.00 million, both compared to the same reporting season a year before and sequentially.

Heart Test Laboratories Inc

Breaking News: Biotech Firm HSCS Reveals Surprising Q4-2023 Financial Results; Shareholders in Shock! and Unexpected Financial Developments at Heart Test Laboratories Inc. in Q1 2023, Operating Shortfall Reaches $1.6 Million.



In the surprising turn of events, Heart Test Laboratories Inc, a leading Biotechnology & Pharmaceuticals company, has recently reported financial results that deviated from the stockholders' expectations. The company's operating shortfall amounted to $-1.598659 million during the earnings season of February to April 2023. Moreover, Heart Test Laboratories Inc recorded a net loss of $-1.632 million, as opposed to break-even in the corresponding reporting period the previous year. These unforeseen results have left investors wondering about the potential implications for the company's future.
1. Narrowing Margins:
The operating shortfall of $-1.598659 million during the latest earnings season indicates that Heart Test Laboratories Inc struggled to generate sufficient revenue to cover its operating expenses. This suggests that the company's gross margins may have contracted during this period. Such a decline in margins may raise concerns among stockholders regarding the overall financial health and profitability of the company.






 

Heart Test Laboratories Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com